Kleinsteuber et al., 2016 - Google Patents
Standardization and quality control for high‐dimensional mass cytometry studies of human samplesKleinsteuber et al., 2016
View PDF- Document ID
- 17255167949476907597
- Author
- Kleinsteuber K
- Corleis B
- Rashidi N
- Nchinda N
- Lisanti A
- Cho J
- Medoff B
- Kwon D
- Walker B
- Publication year
- Publication venue
- Cytometry Part A
External Links
Snippet
Mass cytometry (CyTOF), a mass spectrometry‐based single cell phenotyping technology, allows utilization of over 35 antibodies in a single sample and is a promising tool for translational human immunology studies. Although several analysis tools are available to …
- 238000004163 cytometry 0 title abstract description 42
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kleinsteuber et al. | Standardization and quality control for high‐dimensional mass cytometry studies of human samples | |
Gadalla et al. | Validation of CyTOF against flow cytometry for immunological studies and monitoring of human cancer clinical trials | |
Cader et al. | A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma | |
Cader et al. | Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment | |
Ijsselsteijn et al. | A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry | |
Behbehani et al. | Single‐cell mass cytometry adapted to measurements of the cell cycle | |
Sayin et al. | Spatial distribution and function of T follicular regulatory cells in human lymph nodes | |
Hartmann et al. | A universal live cell barcoding-platform for multiplexed human single cell analysis | |
Perez‐Pujol et al. | Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer | |
Lai et al. | A CD45‐based barcoding approach to multiplex mass‐cytometry (CyTOF) | |
Apodaca et al. | Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells | |
Leipold et al. | Comparison of CyTOF assays across sites: Results of a six-center pilot study | |
Kadić et al. | Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determined by multiparametric single cell mass cytometry analysis | |
Clutton et al. | A reproducible, objective method using MitoTracker® fluorescent dyes to assess mitochondrial mass in T cells by flow cytometry | |
Kawamoto et al. | Frequent expression of CD 30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD 30 antibody‐based therapy | |
Wei et al. | Flow cytometric analysis of circulating follicular helper T (Tfh) and follicular regulatory T (Tfr) populations in human blood | |
Rasmussen et al. | Stable phenotype of B‐cell subsets following cryopreservation and thawing of normal human lymphocytes stored in a tissue biobank | |
Lowes et al. | User‐defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system | |
Mavropoulos et al. | Simultaneous detection of protein and mRNA in Jurkat and KG‐1a cells by mass cytometry | |
Akkaya et al. | A simple, versatile antibody-based barcoding method for flow cytometry | |
Hofmann et al. | Surfaceome of classical Hodgkin and non‐Hodgkin lymphoma | |
Giudice et al. | Optimization and standardization of fluorescent cell barcoding for multiplexed flow cytometric phenotyping | |
Li et al. | Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum samples from patients with hematological malignancies | |
US20190079094A1 (en) | Subcellular localization of target analytes | |
Biancotto et al. | OMIP-004: in-depth characterization of human T regulatory cells |